Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 9 | $9,071,241 |
| Sells | 24 | $4,227,038 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 01 Apr 2024 21:31 | RPTX | Repare Therapeutics Inc | SEGAL LLOYD MITCHELL | PRESIDENT AND CEO | 01 Apr 2024 | Sale | 2,491 | 4.63 | 11,533 | I |
| 01 Apr 2024 21:31 | RPTX | Repare Therapeutics Inc | SEGAL LLOYD MITCHELL | PRESIDENT AND CEO | 28 Mar 2024 | Sale | 2,650 | 4.62 | 12,243 | I |
| 01 Apr 2024 21:30 | RPTX | Repare Therapeutics Inc | FORTE STEVE | EVP, CHIEF FINANCIAL OFFICER | 01 Apr 2024 | Sale | 789 | 4.61 | 3,637 | D |
| 01 Apr 2024 21:30 | RPTX | Repare Therapeutics Inc | FORTE STEVE | EVP, CHIEF FINANCIAL OFFICER | 28 Mar 2024 | Sale | 825 | 4.62 | 3,812 | D |
| 01 Apr 2024 21:28 | RPTX | Repare Therapeutics Inc | ZINDA MICHAEL | EVP, CHIEF SCIENTIFIC OFFICER | 01 Apr 2024 | Sale | 410 | 4.66 | 1,911 | D |
| 01 Apr 2024 21:28 | RPTX | Repare Therapeutics Inc | ZINDA MICHAEL | EVP, CHIEF SCIENTIFIC OFFICER | 28 Mar 2024 | Sale | 450 | 4.64 | 2,088 | D |
| 01 Apr 2024 21:27 | RPTX | Repare Therapeutics Inc | KOEHLER MARIA | EVP, CHIEF MEDICAL OFFICER | 01 Apr 2024 | Sale | 300 | 4.66 | 1,398 | D |
| 01 Apr 2024 21:27 | RPTX | Repare Therapeutics Inc | KOEHLER MARIA | EVP, CHIEF MEDICAL OFFICER | 28 Mar 2024 | Sale | 500 | 4.64 | 2,320 | D |
| 27 Mar 2024 18:59 | RPTX | Repare Therapeutics Inc | FORTE STEVE | EVP, CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Sale | 825 | 4.62 | 3,812 | D |
| 27 Mar 2024 18:59 | RPTX | Repare Therapeutics Inc | FORTE STEVE | EVP, CHIEF FINANCIAL OFFICER | 26 Mar 2024 | Sale | 825 | 4.6 | 3,795 | D |
| 27 Mar 2024 18:59 | RPTX | Repare Therapeutics Inc | FORTE STEVE | EVP, CHIEF FINANCIAL OFFICER | 25 Mar 2024 | Sale | 825 | 4.79 | 3,952 | D |
| 27 Mar 2024 18:57 | RPTX | Repare Therapeutics Inc | ZINDA MICHAEL | EVP, CHIEF SCIENTIFIC OFFICER | 27 Mar 2024 | Sale | 450 | 4.62 | 2,079 | D |
| 27 Mar 2024 18:57 | RPTX | Repare Therapeutics Inc | ZINDA MICHAEL | EVP, CHIEF SCIENTIFIC OFFICER | 26 Mar 2024 | Sale | 450 | 4.61 | 2,074 | D |
| 27 Mar 2024 18:57 | RPTX | Repare Therapeutics Inc | ZINDA MICHAEL | EVP, CHIEF SCIENTIFIC OFFICER | 25 Mar 2024 | Sale | 450 | 4.78 | 2,151 | D |
| 27 Mar 2024 18:56 | RPTX | Repare Therapeutics Inc | KOEHLER MARIA | EVP, CHIEF MEDICAL OFFICER | 27 Mar 2024 | Sale | 500 | 4.62 | 2,310 | D |
| 27 Mar 2024 18:56 | RPTX | Repare Therapeutics Inc | KOEHLER MARIA | EVP, CHIEF MEDICAL OFFICER | 26 Mar 2024 | Sale | 500 | 4.6 | 2,300 | D |
| 27 Mar 2024 18:56 | RPTX | Repare Therapeutics Inc | KOEHLER MARIA | EVP, CHIEF MEDICAL OFFICER | 25 Mar 2024 | Sale | 500 | 4.78 | 2,390 | D |
| 27 Mar 2024 18:54 | RPTX | Repare Therapeutics Inc | SEGAL LLOYD MITCHELL | PRESIDENT AND CEO | 27 Mar 2024 | Sale | 2,650 | 4.63 | 12,270 | I |
| 27 Mar 2024 18:54 | RPTX | Repare Therapeutics Inc | SEGAL LLOYD MITCHELL | PRESIDENT AND CEO | 26 Mar 2024 | Sale | 2,650 | 4.64 | 12,296 | I |
| 27 Mar 2024 18:54 | RPTX | Repare Therapeutics Inc | SEGAL LLOYD MITCHELL | PRESIDENT AND CEO | 25 Mar 2024 | Sale | 2,650 | 4.79 | 12,694 | I |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 16 Nov 2023 | Purchase | 16,143 | 5.3837 | 86,909 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 16 Nov 2023 | Purchase | 125,909 | 5.3837 | 677,856 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 16 Nov 2023 | Purchase | 153,693 | 5.3837 | 827,437 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 15 Nov 2023 | Purchase | 47,712 | 4.9999 | 238,555 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 15 Nov 2023 | Purchase | 390,507 | 4.9999 | 1,952,496 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 15 Nov 2023 | Purchase | 493,337 | 4.9999 | 2,466,636 | D |
| 03 Nov 2023 17:37 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 02 Nov 2023 | Purchase | 72,479 | 3.6 | 260,924 | D |
| 03 Nov 2023 17:37 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 02 Nov 2023 | Purchase | 492,251 | 3.6 | 1,772,104 | D |
| 03 Nov 2023 17:37 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 02 Nov 2023 | Purchase | 218,979 | 3.6 | 788,324 | D |
| 09 Jun 2023 16:25 | RPTX | Repare Therapeutics Inc | ZINDA MICHAEL | EVP, Chief Scientific Officer | 08 Jun 2023 | Sale | 2,869 | 12.02 | 34,485 | D |
| 09 Jun 2023 16:25 | RPTX | Repare Therapeutics Inc | ZINDA MICHAEL | EVP, Chief Scientific Officer | 07 Jun 2023 | Sale | 6,404 | 12.03 | 77,040 | D |
| 07 Jun 2023 16:55 | RPTX | Repare Therapeutics Inc | ZINDA MICHAEL | EVP, Chief Scientific Officer | 06 Jun 2023 | Sale | 1,200 | 12.04 | 14,448 | D |
| 13 Dec 2022 16:18 | RPTX | Repare Therapeutics Inc | JEREL DAVIS | Director | 09 Dec 2022 | Sale | 250,000 | 16 | 4,000,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)